Wall Street Backs Science: Cancer Drugmaker CG Oncology Raises $380M in Hot IPO
New York, NY (January 25, 2024) – The biotech sector, which has faced headwinds in
New HIV Vaccine Trial Begins in US and South Africa
A trial of a preventive HIV vaccine candidate has begun enrollment in the United States
The Future of Healthcare: Exploring the Impact of Digital Transformation on the Medical Device Industry
https://www.youtube.com/watch?v=2s2PeKF_Iik&t=10s Corpradar recently had a discussion with a Director and Chief Transformation Officer, GBS APAC,
How Life Sciences Companies are winning with powerful workforce
The massive bioscience industry, which includes biotechnology, pharmaceuticals, medical devices, and research organisations, among others,
The next big fear for biotech: a “delisting” letter from the Nasdaq
The latest fear plaguing biotech boardrooms isn’t a failed experiment or a huge financial push,
Why are most clinical trials failing because of the impact of AI?
Artificial intelligence (AI) research in healthcare is growing, with potential applications being proven across a
Astellas New Menopause Drug Fails to Gain FDA Approval.
Astellas’ effort to launch menopause drug candidate fezolinetant hit a snag at the last minute.
John Reed soars to the top of the ladder at J&J
John Reed, M.D., Ph.D., Head of Global R&D at Sanofi, has moved to Johnson &
Mineralys Upsizes IPO to raise $192M, Seeks to Race Ahead of AstraZeneca
After a long winter, the first signs of spring have brought a smaller patch of